Literature DB >> 19208885

Peruvian Vibrio cholerae O1 El Tor strains possess a distinct region in the Vibrio seventh pandemic island-II that differentiates them from the prototype seventh pandemic El Tor strains.

Suraia Nusrin1, Ana I Gil2, N A Bhuiyan1, Ashrafus Safa3, Masahiro Asakura4, Claudio F Lanata2, E Hall5, H Miranda6, B Huapaya7, Carmen Vargas G8, M A Luna9, D A Sack10, Shinji Yamasaki4, G Balakrish Nair11.   

Abstract

A collection of environmental and clinical strains of Vibrio cholerae O1 isolated from the beginning of the Latin American epidemic of cholera in 1991 to 2003 from multiple locations in Peru were characterized and compared with V. cholerae O1 El Tor strains of the seventh pandemic from the rest of the world (Asia, Africa, Australia and Europe) using a multilocus virulence gene profiling strategy and DNA sequencing. Peruvian strains differed from El Tor strains from the rest of the world by the failure of PCR to amplify genes VC0512, VC0513, VC0514 and VC0515 in the Vibrio seventh pandemic island-II (VSP-II) gene cluster. Sequencing of the VSP-II gene cluster and its flanking regions in one Peruvian strain (PERU-130) confirmed the PCR results, indicating that the Peruvian strain had low DNA homology (46.6 %) compared to the reference strain N16961 within the VSP-II region encompassing genes VC0511 to VC0515. Based on these differences in VSP-II, and based on the overall similarity between the pulsotypes of the Peruvian strains and the El Tor reference strain N16961, we concluded that the Peruvian, Eurasian and African strains belonged to the same clonal complex, and that the Peruvian strains represented variants that had independently evolved for a relatively short time. Since these ORFs in VSP-II of Peruvian strains are unique and conserved, they could form the basis for tracking the origin of the Peruvian strains and therefore of the Latin American pandemic.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19208885     DOI: 10.1099/jmm.0.005397-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  18 in total

1.  Complete genome sequence of a sucrose-nonfermenting epidemic strain of Vibrio cholerae O1 from Brazil.

Authors:  Lena Lillian Canto de Sá Morais; Daniel Rios Garza; Edvaldo Carlos Brito Loureiro; Keley Nascimento Barbosa Nunes; Rodrigo Silvestre Vellasco; Clayton Pereira da Silva; Márcio Roberto Texeira Nunes; Cristiane Carneiro Thompson; Ana Carolina Paulo Vicente; Elisabeth Conceição de Oliveira Santos
Journal:  J Bacteriol       Date:  2012-05       Impact factor: 3.490

2.  Occurrence in Mexico, 1998-2008, of Vibrio cholerae CTX+ El Tor carrying an additional truncated CTX prophage.

Authors:  Munirul Alam; Shah Manzur Rashed; Shahnewaj Bin Mannan; Tarequl Islam; Marcial Leonardo Lizarraga-Partida; Gabriela Delgado; Rosario Morales-Espinosa; Jose Luis Mendez; Armando Navarro; Haruo Watanabe; Makoto Ohnishi; Nur A Hasan; Anwar Huq; R Bradley Sack; Rita R Colwell; Alejandro Cravioto
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

3.  Discovery of novel Vibrio cholerae VSP-II genomic islands using comparative genomic analysis.

Authors:  Elisa Taviani; Christopher J Grim; Jinna Choi; Jongsik Chun; Bradd Haley; Nur A Hasan; Anwar Huq; Rita R Colwell
Journal:  FEMS Microbiol Lett       Date:  2010-05-06       Impact factor: 2.742

4.  The origin of the Haitian cholera outbreak strain.

Authors:  Chen-Shan Chin; Jon Sorenson; Jason B Harris; William P Robins; Richelle C Charles; Roger R Jean-Charles; James Bullard; Dale R Webster; Andrew Kasarskis; Paul Peluso; Ellen E Paxinos; Yoshiharu Yamaichi; Stephen B Calderwood; John J Mekalanos; Eric E Schadt; Matthew K Waldor
Journal:  N Engl J Med       Date:  2010-12-09       Impact factor: 91.245

5.  Vibrio cholerae classical biotype strains reveal distinct signatures in Mexico.

Authors:  Munirul Alam; M Tarequl Islam; Shah Manzur Rashed; Fatema-tuz Johura; Nurul A Bhuiyan; Gabriela Delgado; Rosario Morales; Jose Luis Mendez; Armando Navarro; Haruo Watanabe; Nur-A Hasan; Rita R Colwell; Alejandro Cravioto
Journal:  J Clin Microbiol       Date:  2012-04-18       Impact factor: 5.948

6.  Cholera between 1991 and 1997 in Mexico was associated with infection by classical, El Tor, and El Tor variants of Vibrio cholerae.

Authors:  Munirul Alam; Suraia Nusrin; Atiqul Islam; Nurul A Bhuiyan; Niaz Rahim; Gabriela Delgado; Rosario Morales; Jose Luis Mendez; Armando Navarro; Ana I Gil; Haruo Watanabe; Masatomo Morita; G Balakrish Nair; Alejandro Cravioto
Journal:  J Clin Microbiol       Date:  2010-07-28       Impact factor: 5.948

7.  Drug response and genetic properties of Vibrio cholerae associated with endemic cholera in north-eastern Thailand, 2003-2011.

Authors:  Chariya Chomvarin; Fatema-Tuz Johura; Shahnewaj B Mannan; Warin Jumroenjit; Boonnapa Kanoktippornchai; Waraluk Tangkanakul; Napaporn Tantisuwichwong; Sriwanna Huttayananont; Haruo Watanabe; Nur A Hasan; Anwar Huq; Alejandro Cravioto; Rita R Colwell; Munirul Alam
Journal:  J Med Microbiol       Date:  2013-01-14       Impact factor: 2.472

Review 8.  Genomic science in understanding cholera outbreaks and evolution of Vibrio cholerae as a human pathogen.

Authors:  William P Robins; John J Mekalanos
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

9.  Multi-drug resistant Vibrio cholerae O1 variant El Tor isolated in northern Vietnam between 2007 and 2010.

Authors:  Huu Dat Tran; Munirul Alam; Nguyen Vu Trung; Nguyen Van Kinh; Hong Ha Nguyen; Van Ca Pham; Mohammad Ansaruzzaman; Shah Manzur Rashed; Nurul A Bhuiyan; Tuyet Trinh Dao; Hubert P Endtz; Heiman F L Wertheim
Journal:  J Med Microbiol       Date:  2011-10-20       Impact factor: 2.472

10.  Cholera outbreaks in Nigeria are associated with multidrug resistant atypical El Tor and non-O1/non-O139 Vibrio cholerae.

Authors:  Michel A Marin; Cristiane C Thompson; Fernanda S Freitas; Erica L Fonseca; A Oladipo Aboderin; Sambo B Zailani; Naa Kwarley E Quartey; Iruka N Okeke; Ana Carolina P Vicente
Journal:  PLoS Negl Trop Dis       Date:  2013-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.